255 / 294
255
Biophysical Society 59
th
Annual Meeting, Baltimore, Maryland
Name
Disclosure Entity
Disclosure Type
Presentation Number
Pierson, Jason
FEI Company
Employment (full or part-time) in funding company 1441-Pos
Piterman, Nir
Microsoft
Employment (full or part-time) in funding company 1833-Plat
Prummer, Michael
F. Hoffmann-La Roche Ltd.
Employment (full or part-time) in funding company 1626-Pos
Rajamani, Sridharan
Gilead Sciences
Employment (full or part-time) in funding company 1395-Pos
Ramdoski, Chris
Xenon Phamaceuticals
Employment (full or part-time) in funding company 2912-Pos
Rammohan, Aravind
Corning, Inc.
Employment (full or part-time) in funding company 1533-Pos
Rasmusson, Randall
Cytocybernetics
Ownership or Partnership in funding organization 560-Pos
Rasmusson, Randall
Cytocybernetics
Ownership or Partnership in funding organization 561-Pos
Rasmusson, Randall
Cytocybernetics
Ownership or Partnership in funding organization 1366-Pos
Rau, Michael
Agilent
Research funded by industry grant
1189-Pos
Reichelt, Mike
Genentech, Incorporated, a
member of the Roche Group
Employment (full or part-time) in funding company 810-Pos
Reifenberger, Jeff
BioNano Genomics
Employment (full or part-time) in funding company 742-Pos
Robey, Seth
Gilead Sciences
Research funded by industry grant
2953-Pos
Sahin, Ozgur
Bruker-nano, Inc.
Receipt of royalties from referenced company
products
1780-Plat
Sarangarajan, Rangaprasad
Berg LLC
Employment (full or part-time) in funding company 1243-Pos
Scheel, Olaf
Cytocentrics Bioscience GmbH Employment (full or part-time) in funding company 2954-Pos
Seeliger, Daniel
Boehringer Ingelheim
Employment (full or part-time) in funding company 2087-Pos
Shorthouse, David
Lonza Biologics
Research funded by industry grant
2500-Plat
Silverberg, Jesse
R.J., M.D., M.S.A., J.B.W. and
P.Y. have filed a provisional US
patent application regarding the
current work
Other
2407-Pos
Sitte, Harald
Torrex-Chiesi Pharma
Consulting fees or other remuneration from industry 999-Symp
Sitters, Gerrit
LUMICKS
Receipt of royalties from referenced company
products
2557-Plat
Skupin, Michalina
Acknowledgments: The study
was supported by research
grant „GENERACJA PR-
ZYSZŁOŚCI”
from Ministry of Science and
Higher Education (Poland) –
decision: 12/POIG/GP/2013.
Other
1239-Pos
Sliwkowski, Mark
Genentech, Incorporated, a
member of the Roche Group
Employment (full or part-time) in funding company 810-Pos
Smith, Godfrey
Shareholder in Clyde Bioscience
Ltd (UK)
Other
1380-Pos
Srivastava, Amit
MedImmune Ltd
Research funded by industry grant
1893-Pos
Stolarska, Magdalena
Corning, Inc.
Consulting fees or other remuneration from industry 1533-Pos
Swanson, Brad
CDI
Employment (full or part-time) in funding company 2968-Pos
Tate, Christopher
Heptares Therapeutics
Consulting fees or other remuneration from industry 210-Wkshp
Taylor, J.
Third Rock Ventures
Consulting fees or other remuneration from industry 27-Subg
Theile, Jonathan
Pfizer, Inc.
Employment (full or part-time) in funding company 2902-Pos
Thomas, Dierk
MSD Sharp and Dohme
Research funded by industry grant
552-Pos